Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Musculoskeletal Transplant Foundation has 6 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 6 examiners and 6 art units, indicating that every listed matter follows a distinct examination assignment.
FOX, ALLISON M is the busiest identified examiner, with 1 pending matter. Since no examiner or art unit carries a larger concentration, prosecution planning should emphasize individual claim sets, evidence, and response strategy.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §103 only | 1 (20%) |
| §112 only | 1 (20%) |
| Double-patenting + other | 1 (20%) |
| Multi-statute (no §101) | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FOX, ALLISON M | 1 | 71.0% | +35.7% |
| WERTZ, ASHLEE ELIZABETH | 1 | 52.7% | +35.6% |
| VAN BUREN, LAUREN K | 1 | 40.0% | +58.4% |
| DUDDEN, TERESA MARIE | 1 | 48.1% | +45.2% |
| PRONE, CHRISTOPHER D | 1 | 64.9% | +19.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18591564 | CARTILAGE-DERIVED IMPLANTS AND METHODS OF MAKING AND USING SAME | DUDDEN, TERESA MARIE | — |
| 17728384 | TISSUE DERIVED IMPLANTS REHYDRATABLE WHILE DISPOSED WITHIN A DEVICE | PRONE, CHRISTOPHER D | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18608371 | PLACENTAL TISSUE PARTICULATE COMPOSITIONS AND METHODS OF USE | VAN BUREN, LAUREN K | 4d overdue |
| 19183186 | MIXTURES OF PLACENTAL PARTICLES, GRAFTS INCLUDING THEM, AND METHODS FOR MAKING AND USING THEM | FOX, ALLISON M | — |
| 18807214 | SHAPED AMALGAMATED CARTILAGE GRAFTS AND METHODS FOR MAKING AND USING SAME | WERTZ, ASHLEE ELIZABETH | — |
| 18591564 | CARTILAGE-DERIVED IMPLANTS AND METHODS OF MAKING AND USING SAME | DUDDEN, TERESA MARIE | — |
| 17728384 | TISSUE DERIVED IMPLANTS REHYDRATABLE WHILE DISPOSED WITHIN A DEVICE | PRONE, CHRISTOPHER D | — |
| Art Unit | Apps |
|---|---|
| 1633 | 1 |
| 1612 | 1 |
| 1638 | 1 |
| 1631 | 1 |
| 3774 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19183186 | MIXTURES OF PLACENTAL PARTICLES, GRAFTS INCLUDING THEM, AND METHODS FOR MAKING AND USING THEM | FOX, ALLISON M | 1633 | §112 | Non-Final OA | — | Pending | Apr 18, 2025 |
| 18807214 | SHAPED AMALGAMATED CARTILAGE GRAFTS AND METHODS FOR MAKING AND USING SAME | WERTZ, ASHLEE ELIZABETH | 1612 | §102§103DP | Non-Final OA | — | Pending | Aug 16, 2024 |
| 18608371 | PLACENTAL TISSUE PARTICULATE COMPOSITIONS AND METHODS OF USE | VAN BUREN, LAUREN K | 1638 | §103 | Final Rejection | 4d overdue | Pending | Mar 18, 2024 |
| 18591564 | CARTILAGE-DERIVED IMPLANTS AND METHODS OF MAKING AND USING SAME | DUDDEN, TERESA MARIE | 1631 | §101§102§103§112 | Non-Final OA | — | Pending | Feb 29, 2024 |
| 17728384 | TISSUE DERIVED IMPLANTS REHYDRATABLE WHILE DISPOSED WITHIN A DEVICE | PRONE, CHRISTOPHER D | 3774 | §102§103§112 | Non-Final OA | — | Pending | Apr 25, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMusculoskeletal Transplant Foundation has 5 pending office actions as of October 2026, spread across 5 art units and 5 examiners.
Allison M Fox has the most, with 1 of Musculoskeletal Transplant Foundation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
